Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence-Reference-Cited by-同舟云学术

Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence

Published:2007-12 Issue:6 Volume:30 Page:477-486
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Falagas Matthew E.,Voidonikola Paraskevi T.,Angelousi Anna G.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference46 articles.

1. High risk of tuberculosis in systemic lupus erythematosus?;Erdozain;Lupus,2006

2. Opportunistic infections in polymyositis and dermatomyositis;Marie;Arthritis Rheum,2005

3. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy;Mok;J Rheumatol,2005

4. Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization;Sayarlioglu;Lupus,2004

5. Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long-term steroid treatment;Gaitonde;Ann Rheum Dis,2002

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Adverse Events during Treatment of Tuberculosis in the Patient with Systemic Lupus Erythematosus;Tuberculosis and Lung Diseases;2023-08-29

2. Misdiagnosis of Systemic Lupus Erythematosus Combined with Urinary Tuberculosis Leading to Tuberculous Meningitis: A Case Report and Literature Review;Infection and Drug Resistance;2023-07

3. Prevalence of latent tuberculosis infection among patients with interstitial lung disease requiring immunosuppression;Jornal Brasileiro de Pneumologia;2022-04-30

4. Systemic lupus erythematosus and infections;Systemic Lupus Erythematosus;2021

5. Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids;PLOS ONE;2020-12-31